Fischer Imaging is focused on improving breast cancer screening and diagnosis by finding missed cancers and reducing unnecessary treatment.

Responsible for all aspects of product development, quality compliance, regulatory approval, reimbursement and product launch. Liaison with research institutions and leading investigators performing neuro-surgical procedures.

LumaMed is a medical device company focused on developing tools for “real time” intraoperative tissue imaging and margin evaluation during cancer surgery. The information in the images produced by our method rival those obtained in conventional histopathology. The “real time” imaging reduces morbidity and cost, allows immediate reconstruction and adjuvant therapy, reduces infection risk and liability and improves outcomes.* Winner Women 2.0 Pitch 2009: Also won the People’s Choice Award, and VentureBeat Best Media Story Award. http://women2.com/pitch-2009-winner-lumaderm/* NIH SBIR Phase I grant award. 2013

Twenty years of experience in developing medical diagnostic and imaging products and inventor of the technology platform. Program manager on a collaboration with Konica Minolta (Japan) for developing a system for identifying patients at risk of developing esophageal cancer. Instrumental in the successful launch of two point-of-care medical diagnostic products, the AVL/Roche OPTI 2® blood chemistry analyzer and the Guided Therapeutics BiliChek® Non-invasive Bilirubin Analyzer. Inventor on 8 patents and authored several publications and presentations in the areas of clinical monitoring and diagnostics. Recipient of multiple NIH SBIR grants totaling in excess of $6.0 million for developing non-invasive diagnostic devices. Extensive experience with regulatory strategy and FDA 510K & PMA applications, quality systems compliance, clinical studies and regulations for conducting research on human subjects.* NIH SBIR success story http://sbir.cancer.gov/success/stories/guided_therapeutics/index.asp